General Information

Government Type

State Agency

Entity

Department of Health and Human Services (DHHS)

Public Body

Pharmacy and Therapeutics Committee

Notice Information

Add Notice to Calendar

Notice Title

Pharmacy & Therapeutics Committee Meeting

Notice Tags

Medicaid, Pharmacies

Notice Type(s)

Meeting

Event Start Date & Time

March 21, 2013 07:00 AM

Event End Date & Time

March 21, 2013 08:30 AM

Event Deadline Date & Time

03/14/13 06:00 PM

Description/Agenda

UTAH DEPARTMENT OF HEALTH STATE MEDICAID PHARMACY AND THERAPEUTICS COMMITTEE Thursday, March 21, 2013 7:00 a.m. to 8:30 a.m. Cannon Health Building Room 128 (NOTE: Room Change) AGENDA Please note that persons who wish to address the P&T Committee may contact Lisa V. Hunt (lvhunt@utah.gov) at least 7 calendar days prior to the meeting. Comments from visitors, while welcome, may be limited due to time constraints 1) Welcome and Introductions.........................................................Chair, Ellie Brownstein, M.D. a) Review and Approval of Minutes 2) Update on PDL Administration…………...............................................Lisa V. Hunt, R.Ph a) Housekeeping. 3) DUR Board Update..................................................................................Robyn Seely, PharmD 4) Multiple Sclerosis Agents Update Agents to include: Fingolimod (Gilenya®), Dalfampridine (Ampyra™). a. Over view of Clinical Outcomes…………………………………Melissa Archer, PharmD b. Other States Report………………………………………………….. Lisa V. Hunt, R.Ph. c. Public Comment………………………………………………………………………….. Deborah Profant, Ph.D., Medical Science Liaison, Teva Pharmaceuticals Evan Riddle, PharmD., Medical Science Liaison, Biogen Idec d. Board Discussion/Questions e. Board Action 5) Meeting Adjourned………………………………….........Chair, Ellie Brownstein, M.D. Public comment that responds to the materials presented by the College of Pharmacy @University of Utah is most helpful. The foundation documents used for most reviews are prepared by the Oregon Evidence-based Practice Center or the University of Utah College of Pharmacy and are posted in advance on the P&T Committee website. Manufacturers are requested to submit any additional materials they would like reviewed as part of the process to: Dr. Gary Oderda College of Pharmacy 30 South 2000 East SLC, UT 84112-5820 All materials must be clearly labeled that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible) after the Oregon monograph was prepared, unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search. Tentative Utah Medicaid P&T Schedule 2013 April 18, 2013 Sulfonylurea Drug Class Review Agents to include: Chlorpropamide, Gliclazide, Glimepiride, Glipizide, Glyburide, Tolazamide, Tolbutamide Sedative Hypnotics Recommendation Clarification Agents to include: Eszopiclone, Ramelteon, Zaleplon, Zolpidem Sulfonylurea Combination Products Drug Agents to include: Metformin/Glipizide, Metformin/Glyburide May 16, 2013 Thiazolidinedione Drug Class Review Agents to include: Pioglitazine, Rosiglitazone Thiazolidindione Combination Products Drug Class Review Agents to include: Metformin/Pioglitazine, Metformin/Rosiglitazone, Glimepiride/Pioglitazine, Glimepiride/Rosiglitazone June – Cancelled due to bid review July 18, 2013 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Drug Class Review Agents to include: Exenatide (Byetta®), Liraglutide (Victoza®) August 15, 2013 Phosphate Binding Agents Drug Class Review Agents to include: Calcium Acetate (Eliphos™; PhosLo®; Phoslyra™), Lanthanum (Fosrenol®), Sevelamer Renagel®) September 19, 2013 Topical Immune-modulators Drug Class Review Agents to include: Pimecrolimus (Elidel®); Tacrolimus (Protopic®) October 17, 2013 Topical/Local Anesthetic Agents Drug Class Review Agents to include: Articaine, Benzocaine, Benzydamine, Benzyl Alcohol, Bupivacaine, Capsaicin, Cetylpyridinium, Chloroprocaine, Dibucaine, Dyclonine, Ethyl Chloride, Hexylresorcinol, Lidocaine, Mepivacaine, Pramoxine, Prilocaine, Proparacaine, Ropivacaine, Tetracaine, Trolamine, Zucapsaicin November 21, 2013 Pediculoside Agents Drug Class Review Agents to include: Benzyl Alcohol, Ivermectin, Lindane, Malathion, Permethrin, Pyrethrins and Piperonyl Butoxide, Spinosad December 19, 2013 Opioid Agents Agents to include: Short-acting Agents Immediate-acting Agents

Notice of Special Accommodations (ADA)

NOTICE OF SPECIAL ACCOMMODATION DURING PUBLIC MEETINGS In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Lisa Hunt at 801-538-6317.

Notice of Electronic or Telephone Participation

NOTICE OF POSSIBLE ELECTRONIC OR TELEPHONIC PARTICIPATION One or more members of the Pharmacy & Therapeutics Committee may participate electronically or telephonically pursuant to UCA 52-4-7.8

Meeting Information

Meeting Location

288 North 1460 West
Cannon Health Building, Room 128
Salt Lake City, 84116
Show in Apple Maps Show in Google Maps

Contact Name

Ngan Huynh

Contact Email

nganhuynh@utah.gov

Contact Phone

801-538-6155

Notice Posting Details

Notice Posted On

March 04, 2013 02:33 PM

Notice Last Edited On

March 07, 2013 09:06 AM

Deadline Date

March 14, 2013 06:00 PM

Subscribe by Email

Subscription options will send you alerts regarding future notices posted by this Body.